TMED3 and prostate carcinoma: Herein, the KEGG pathway enrichment analysis was performed to investigate the possible downstream cooperator of TMED3 in prostate cancer, and a strong correlation between TMED3 and FOXO signaling pathway phosphorylation was observed.